The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's ...

Scientists have recently shown that both the quality and the amount of sleep we get may influence our risk of developing ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the conclusion of an international team of researchers who studied the sleep patterns ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Recent studies have shown that both the quality and the amount of sleep we get may influence our risk of developing Alzheimer ...

Researchers have linked daily consumption of certain amounts of processed red meats to increased dementia risk, but some ...

Officials said they are asking for the public's help in finding a missing 86-year-old man who suffers from Alzheimer's disease in Waldorf, Maryland.

Deputies in Charles County are looking for an 86-year-old man after he went missing from a Waldorf home. In a post on the X ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.